I can't tell without hearing his words at the presentation (especially whether an explanation for all the missing data was stated. He did not prepare the company slides.
I don’t think he is, in the sense that the results are encouraging for a new P3 trial designed to iron out the titration difficulties and with a larger n that includes ethnic diversity.